Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06432374 · ClinicalTrials.gov registry record · Early Phase 1
Written Exposure Therapy for Nurses
A Early Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT06432374 is a Early Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 10 participants.
The verdict
NCT06432374, a Early Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Nurses often experience elevated levels of stress, overwork, and trauma in the workplace, leading to posttraumatic stress disorder (PTSD), depression, burnout, and even nurse turnover. While effective therapies for PTSD exist, barriers to treatment arise from nursing culture, such as workplace stigma about mental health problems, fear that psychological status may impact performance evaluations, and demands of shiftwork. There is a pressing need for scalable evidence-based interventions tailored to nursing culture to effectively address PTSD and related mental health issues. The study aimed to assess the feasibility, safety, and acceptability of a tailored evidence-based treatment, Written Exposure Therapy (WET), for nurses experiencing work-related traumatic stress. This single-arm open pilot study with pre- and post-intervention assessments, included participants from two nursing schools' alumni. Eligibility criteria included nurses screening positive for work-related trauma with a report of at least two PTSD symptoms. Participants engaged in a self-administered, asynchronous, five-week online writing session, facilitated by WET-trained nurses. Outcomes measures (PTSD, depression, anxiety, burnout, and intention to quit) were assessed at baseline, post-intervention, and 5-weeks follow-up.
Interventions
- BEHAVIORAL WET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-09-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06432374
The ClinicalTrials.gov registry entry for NCT06432374 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WET is the first listed.
NCT06432374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06432374 about?
NCT06432374 is a clinical study titled "Written Exposure Therapy for Nurses". Nurses often experience elevated levels of stress, overwork, and trauma in the workplace, leading to posttraumatic stress disorder (PTSD), depression, burnout, and even nurse turnover. While effective therapies for PTSD exist, barriers to treatment arise from nursing culture, such as workplace stigm...
What is the current status of trial NCT06432374?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2022-02-01. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT06432374?
The interventions under investigation include: WET (BEHAVIORAL).
Who is sponsoring clinical trial NCT06432374?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.